HEM Pharma Inc. (KOSDAQ: A376270)
Health Care · Biotechnology · KR
₩31,600.00
-9.06% today · +16.2% 1Y
HEM Pharma Inc. (KOSDAQ: A376270) operates in the Biotechnology industry within the Health Care sector. The company is valued at $169.45M.
Over the last twelve months the share price has gained 16.2%, trading between 25.80K and 97.50K.
Tweenvest scores HEM Pharma Inc. across four factors: quality 35/100, value 63/100. Its strongest factor is value.
A376270 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $169.45M
- Revenue (TTM)
- $10.42M
- P/E
- —
- EPS
- -2,925.70
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- ₩97,500.00
- 52-week low
- ₩25,800.00
- Avg volume (3M)
- —
- Shares outstanding
- 7.21M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| PepGen Inc.NasdaqGS: PEPG | $172.46M | $2.49 | -4.96% |
| Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd.SEHK: 2566 | $172.36M | HK$5.64 | -2.51% |
| ImmuneOnco Biopharmaceuticals (Shanghai) Inc.SEHK: 1541 | $171.05M | HK$3.13 | -7.54% |
| Dx & Vx Co., Ltd.KOSDAQ: A180400 | $170.59M | ₩2,330.00 | -1.48% |
| Medigen Biotechnology Corp.TPEX: 3176 | $168.61M | NT$— | — |
| Canton Strategic Holdings, Inc.NasdaqCM: CNTN | $168.13M | $2.11 | 0.00% |
| AptaBio Therapeutics Inc.KOSDAQ: A293780 | $165.92M | ₩7,940.00 | +1.79% |
| Burning Rock Biotech LimitedNasdaqGM: BNR | $163.36M | $15.00 | -3.16% |
Figures last refreshed Oct 11, 2026.